Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/19/20 → 8/31/50 |
Funding
- Vertex Pharmaceuticals Incorporated
- Ann & Robert H. Lurie Children's Hospital of Chicago
VX19-445-107: A Phase 3, Open-label Study Evaluating theLong-term Safety and Efficacy of VX-445/TEZ/IVACombination Therapy in Subjects With CysticFibrosis Who Are 6 Years of Age and Older
- McColley, Susanna A (PD/PI)
Project: Research project